# Safety and Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived)

> **NCT00424086** · PHASE1,PHASE2 · COMPLETED · sponsor: **Alachua Government Services, Inc.** · enrollment: 1000 (estimated)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Inactivated seasonal influenza vaccine (split virus, vero cell derived)
- **BIOLOGICAL:** Inactivated seasonal influenza vaccine (split virus, egg derived) [licensed control vaccine]

## Key facts

- **NCT ID:** NCT00424086
- **Lead sponsor:** Alachua Government Services, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** —
- **Final completion:** 2007-09
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2015-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00424086

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00424086, "Safety and Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00424086. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*